Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58,548,563
-
Total 13F shares
-
29,405,065
-
Share change
-
-2,109,766
-
Total reported value
-
$49,988,862
-
Put/Call ratio
-
15%
-
Price per share
-
$1.70
-
Number of holders
-
79
-
Value change
-
-$3,977,000
-
Number of buys
-
34
-
Number of sells
-
41
Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q3 2023
As of 30 Sep 2023,
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,405,065 shares.
The largest 10 holders included
Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.